Message Board
                    
                
                     BUDcare® Patient-Derived Tumor Organoid Drug Sensitivity Test Service
BUDcare® Patient-Derived Tumor Organoid Drug Sensitivity Test Service                
                
                    It is a clinical diagnostic service that efficiently and accurately guide cancer patients to the most effective approved anti-tumor drug regimens. This service includes follow steps: 1) starting with in vitro culture and expand of tumor organoid using patient-derived tumor tissue or cancer associated malignant effusions; 2) obtaining drug sensitivity data through anti-tumor drug screening assay; 3) providing a scientific report to help clinicians provide tailored therapeutic regimen for patients.                
                More
             
             
         
             
        

 BUDhealth® Patient-Derived Tumor Organoid Drug Sensitivity Test & NGS Service
BUDhealth® Patient-Derived Tumor Organoid Drug Sensitivity Test & NGS Service                



